Ocrevus and Hepatitis a - a phase IV clinical study of FDA data


Hepatitis a is reported only by a few people who take Ocrevus.

The phase IV clinical study analyzes which people take Ocrevus and have Hepatitis a. It is created by eHealthMe based on reports of 35,378 people who have side effects while taking Ocrevus from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 09, 2022

35,378 people reported to have side effects when taking Ocrevus.
Among them, 4 people (0.01%) have Hepatitis a.

What is Ocrevus?

Ocrevus has active ingredients of ocrelizumab. eHealthMe is studying from 35,402 Ocrevus users for its effectiveness, alternative drugs and more.

What is Hepatitis a?

Hepatitis a is found to be associated with 654 drugs and 303 conditions by eHealthMe.

Number of Ocrevus and Hepatitis a reports submitted per year:

Could Ocrevus cause Hepatitis a?

Time on Ocrevus when people have Hepatitis a *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hepatitis a when taking Ocrevus *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Hepatitis a when taking Ocrevus *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 100 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Ocrevus *:

  1. Keppra: 1 person, 25.00%

Common side effects people have besides Hepatitis a *:

  1. Weight Increased: 1 person, 25.00%
  2. Protein Total Decreased: 1 person, 25.00%
  3. Procalcitonin Increased: 1 person, 25.00%
  4. Mean Cell Haemoglobin Concentration Increased (more concentration of haemoglobin in a given volume of packed red blood cells): 1 person, 25.00%
  5. Lymphocyte Count Decreased: 1 person, 25.00%
  6. Hepatic Pain (pain in liver): 1 person, 25.00%
  7. Gamma-Glutamyltransferase Increased: 1 person, 25.00%
  8. Blood Lactate Dehydrogenase Decreased: 1 person, 25.00%
  9. Blood Bilirubin Increased: 1 person, 25.00%

Common conditions people have *:

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 25.00%
  2. High Blood Pressure: 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ocrevus and have Hepatitis a?

Check whether Hepatitis a is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Hepatitis a and when was it recovered:

Expand to all the drugs that have ingredients of ocrelizumab:

Alternative drugs to, pros and cons of Ocrevus:

Common Ocrevus side effects:

Browse all side effects of Ocrevus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Hepatitis a treatments and more:

COVID vaccines that are related to Hepatitis a:

All the drugs that are associated with Hepatitis a:

All the conditions that are associated with Hepatitis a:

How the study uses the data?

The study uses data from the FDA. It is based on ocrelizumab (the active ingredients of Ocrevus) and Ocrevus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: